Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL INDS | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Specialty insurance provider Assurant Inc. (AIZ - Analyst Report) has declared an increase in its share buyback authorization program, which comes on the heels of an approval to increase dividend announced last week.
The board of directors of Assurant approved the repurchase of up to $600 million of its shares. The new authorization comes on top of $170 million remaining under the existing program as of April 30, 2012.
Assurant will use its healthy cash flow from operations to buyback shares. The company ended the first quarter with $600 million in total holding company capital and has a strong balance sheet with a low debt ratio of 18.2% and no debt maturing until 2014.
Assurant has been aggressively buying back shares. In the first four months of 2012, the company has already bought back 3.3 million shares for a total of $135 million.
The company has bought back approximately 43% of its common shares over the past eight years. It, however, suspended share repurchases in September 2007, when the company faced a SEC investigation regarding certain loss mitigation products. However, the company resumed its buyback plan a year later.
Assurant has a consistent track record of paying back money to its shareholders. Last week, the company hiked its annual dividend payment by 17%, representing the ninth dividend increase since 2004.
Assurant has kept its shareholders happy by actively managing its capital via dividend payment and share buybacks. Share buyback along with dividend payments constituted a total payout ratio of 135% in 2011, which implies that the company distributed 135% of its net income for paying dividends and buying back shares.
Assurant’s different business units are challenged by macroeconomic weakness. While its Employment Benefits business is suffering from a weak payroll, its health business outlook remains uncertain given the impending Health Care Reform decision.
Though its Specialty property business is performing well, earnings from this segment are expected to decline given increased regulatory scrutiny over the rate reduction of forced place insurance. The company’s Solutions business is also suffering from weakness in the U.K though the domestic results continue to be favorable.
Overall, we expect top-line growth at Assurant to remain weak, at least till first half of 2013. In such a scenario, the company’s attractive capital deployment plan will play an important role in maintaining investor confidence.
Assurant closely competes with Allstate Corp. (ALL - Analyst Report), W. R. Berkley Corp. (WRB - Analyst Report), The Travelers Companies Inc. (TRV - Analyst Report). The stock currently retains a Zacks # 3 Rank, which translates into a short-term Hold rating. Considering the fundamentals, we are also maintaining our long-term Neutral recommendation on the shares.
Get the full Analyst Report on AIZ - FREE
Get the full Analyst Report on TRV - FREE
Get the full Analyst Report on WRB - FREE
Get the full Analyst Report on ALL - FREE